Retractable Technologies (NYSE:RVP) Earns Hold Rating from Analysts at StockNews.com

Equities researchers at StockNews.com began coverage on shares of Retractable Technologies (NYSE:RVP) in a research note issued to investors on Thursday. The brokerage set a “hold” rating on the stock.

Retractable Technologies Stock Up 1.7 %

Retractable Technologies stock opened at $0.65 on Thursday. The firm has a fifty day moving average price of $0.71 and a two-hundred day moving average price of $0.92. The firm has a market cap of $19.42 million, a price-to-earnings ratio of -1.20 and a beta of 1.98. The company has a debt-to-equity ratio of 0.01, a current ratio of 8.57 and a quick ratio of 5.92. Retractable Technologies has a fifty-two week low of $0.56 and a fifty-two week high of $1.34.

Insider Activity

In other Retractable Technologies news, CEO Thomas J. Shaw bought 71,422 shares of the stock in a transaction that occurred on Friday, September 20th. The shares were acquired at an average price of $0.82 per share, with a total value of $58,566.04. Following the completion of the purchase, the chief executive officer now directly owns 14,743,907 shares in the company, valued at $12,090,003.74. The trade was a 0.49 % increase in their position. The acquisition was disclosed in a legal filing with the SEC, which is available through the SEC website. Over the last 90 days, insiders purchased 179,279 shares of company stock valued at $136,839. Insiders own 55.00% of the company’s stock.

Institutional Trading of Retractable Technologies

A hedge fund recently bought a new stake in Retractable Technologies stock. PFG Investments LLC bought a new stake in Retractable Technologies, Inc. (NYSE:RVP) during the third quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund bought 34,600 shares of the company’s stock, valued at approximately $27,000. PFG Investments LLC owned 0.12% of Retractable Technologies as of its most recent SEC filing. 7.58% of the stock is owned by institutional investors.

About Retractable Technologies

Retractable Technologies, Inc designs, develops, manufactures, and markets safety syringes and other safety medical products for the healthcare profession in the United States, rest of North and South America, and internationally. The company offers VanishPoint insulin syringes; tuberculin, insulin, and allergy antigen syringes; small diameter tube adapters; blood collection tube holders; allergy trays; IV safety catheters; Patient Safe syringes and Luer Caps; VanishPoint blood collection sets; EasyPoint needles; and VanishPoint autodisable syringes.